Maxnerva Technology Services Limited (HKG:1037)
Hong Kong · Delayed Price · Currency is HKD 0.7100
+0.0100 (1.43%)
Jan 30, 2026, 4:08 PM HKT
HKG:1037 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 642.1 | 558.94 | 677.88 | 832.46 | 596.35 | 523.42 | |
Revenue Growth (YoY) | 10.14% | -17.55% | -18.57% | 39.59% | 13.93% | 21.44% |
Cost of Revenue | 552.8 | 471 | 581.1 | 705.31 | 482.23 | 429.15 |
Gross Profit | 89.3 | 87.94 | 96.78 | 127.15 | 114.12 | 94.26 |
Selling, General & Admin | 76.46 | 82.45 | 91 | 90.72 | 72.78 | 60.29 |
Research & Development | 0.73 | 3.49 | 9.02 | 10.14 | 16.99 | 10.95 |
Other Operating Expenses | 2.12 | -2.76 | -2.52 | -2.71 | -3.96 | -5.41 |
Operating Expenses | 78.54 | 82.41 | 95.98 | 101.5 | 99.24 | 69.33 |
Operating Income | 10.76 | 5.53 | 0.8 | 25.64 | 14.88 | 24.94 |
Interest Expense | -0.27 | -0.27 | -0.21 | -0.51 | -0.85 | -1.21 |
Interest & Investment Income | 1.25 | 2.44 | 1.84 | 1.92 | 2.31 | 2.73 |
Earnings From Equity Investments | -0.11 | -0.02 | -4.73 | -3.32 | - | -0 |
Currency Exchange Gain (Loss) | 2.54 | 2.54 | -0.21 | 4.74 | 2.8 | 0.95 |
EBT Excluding Unusual Items | 14.16 | 10.22 | -2.51 | 28.47 | 19.15 | 27.4 |
Gain (Loss) on Sale of Investments | -6.56 | -17.09 | -1.06 | 2.02 | 18.46 | -5.02 |
Gain (Loss) on Sale of Assets | 0.13 | 0.13 | - | - | -0 | -0 |
Asset Writedown | -2.33 | -2.33 | -10.63 | - | - | - |
Pretax Income | 5.4 | -9.06 | -14.2 | 30.48 | 37.61 | 22.38 |
Income Tax Expense | 4.02 | 3.38 | 2.64 | 2.65 | 3.35 | 7.74 |
Earnings From Continuing Operations | 1.38 | -12.44 | -16.83 | 27.83 | 34.26 | 14.63 |
Net Income | 1.38 | -12.44 | -16.83 | 27.83 | 34.26 | 14.63 |
Net Income to Common | 1.38 | -12.44 | -16.83 | 27.83 | 34.26 | 14.63 |
Net Income Growth | - | - | - | -18.77% | 134.12% | 26.43% |
Shares Outstanding (Basic) | 702 | 702 | 702 | 702 | 691 | 655 |
Shares Outstanding (Diluted) | 702 | 702 | 702 | 702 | 691 | 655 |
Shares Change (YoY) | - | - | - | 1.48% | 5.57% | -0.01% |
EPS (Basic) | 0.00 | -0.02 | -0.02 | 0.04 | 0.05 | 0.02 |
EPS (Diluted) | 0.00 | -0.02 | -0.02 | 0.04 | 0.05 | 0.02 |
EPS Growth | - | - | - | -19.96% | 122.24% | 26.19% |
Free Cash Flow | -48.88 | -1.34 | 31.25 | 20.32 | 13 | 51.01 |
Free Cash Flow Per Share | -0.07 | -0.00 | 0.04 | 0.03 | 0.02 | 0.08 |
Gross Margin | 13.91% | 15.73% | 14.28% | 15.27% | 19.14% | 18.01% |
Operating Margin | 1.68% | 0.99% | 0.12% | 3.08% | 2.50% | 4.76% |
Profit Margin | 0.21% | -2.23% | -2.48% | 3.34% | 5.75% | 2.80% |
Free Cash Flow Margin | -7.61% | -0.24% | 4.61% | 2.44% | 2.18% | 9.74% |
EBITDA | 14.76 | 9.9 | 6.88 | 32.82 | 22.84 | 31.5 |
EBITDA Margin | 2.30% | 1.77% | 1.01% | 3.94% | 3.83% | 6.02% |
D&A For EBITDA | 4 | 4.37 | 6.08 | 7.17 | 7.96 | 6.56 |
EBIT | 10.76 | 5.53 | 0.8 | 25.64 | 14.88 | 24.94 |
EBIT Margin | 1.68% | 0.99% | 0.12% | 3.08% | 2.50% | 4.76% |
Effective Tax Rate | 74.46% | - | - | 8.70% | 8.90% | 34.60% |
Advertising Expenses | - | 0.8 | 1.23 | 1.72 | 0.46 | 0.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.